Apr. Marjan Van Cleemput SRL
Apr. Marjan Van Cleemput reported total assets of 68,105 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Apr. Marjan Van Cleemput shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -49 % Total assets +40 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apr. Marjan Van Cleemput's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Apr. Marjan Van Cleemput's financial analysis
- Solvency36.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apr. Marjan Van Cleemput
Apr. Marjan Van Cleemput's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0729.975.379
- VAT number
- BE0729975379
- Peppol
- Registered · 0208:0729975379 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jul 2019
- Registered office
- 9880 Aalter
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apr. Marjan Van Cleemput (SRL) has been based in Aalter since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 16,638 € and equity of 24,745 €; its revenue is not published. Its solvency stands at 36.3%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apr. Marjan Van Cleemput
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Beukeleirs Holding Retail sale of pharmaceutical products Vielsalm · balance sheet 66,647 €
- TV Retail sale of pharmaceutical products Haacht · balance sheet 65,446 €
- Pharma Laenen Retail sale of pharmaceutical products Geel · balance sheet 64,760 €
- Dorothee Vandevenne Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 64,554 €
- Paula Cosmina Retail sale of pharmaceutical products Ganshoren · balance sheet 64,266 €
- Carva Care Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 72,190 €
- Liscicom Retail sale of pharmaceutical products Bruges · balance sheet 63,926 €
Frequently asked questions about Apr. Marjan Van Cleemput
What is the revenue of Apr. Marjan Van Cleemput?
Apr. Marjan Van Cleemput files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apr. Marjan Van Cleemput?
In Belgium, the VAT number is the company number prefixed with BE: BE0729975379 for Apr. Marjan Van Cleemput, if the company is VAT-registered. Its company number (CBE) is 0729.975.379.
Where is the registered office of Apr. Marjan Van Cleemput?
According to the CBE register, the registered office of Apr. Marjan Van Cleemput is in 9880 Aalter.
What is the equity of Apr. Marjan Van Cleemput?
At the close of the 2025 financial year, the equity of Apr. Marjan Van Cleemput amounts to 24,745 €, a solvency of 36.3% of total assets.
Who manages Apr. Marjan Van Cleemput?
The register lists 1 active mandates at Apr. Marjan Van Cleemput. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apr. Marjan Van Cleemput
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →